SCHEMBL4659282

SCHEMBL4659282

O=[N+]([O-])c1cnc(OCCN2CCOCC2)c(I)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
KMT2A Q03164 3/20 0.48
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 5/20 0.44
MAPT P10636 4/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.43
PKM P14618 2/20 0.42
CYP2C9 P11712 2/20 0.42
HPGD P15428 1/20 0.42
CYP3A4 P08684 1/20 0.41
LMNA P02545 1/20 0.40
KCNJ1 P48048 1/20 0.40
LTA4H P09960 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495264 0.86 ALDH1A1 (0.52) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL28722474 0.86 ALDH1A1 (0.52) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL14397720 0.86 KMT2A (0.54) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL4791655 0.79 HTR2A (0.48) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL4768514 0.77 HTR2A (0.49) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL3386044 0.77 ALDH1A1 (0.54) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL28507375 0.76 CYP2D6 (0.54) SMN1; SMN2KMT2APOLBMEN1ALDH1A1
SCHEMBL14398264 0.74 LTA4H (0.51) SMN1; SMN2KMT2AMEN1ALDH1A1MAPT
SCHEMBL519451 0.73 LTA4H (0.71) SMN1; SMN2ALDH1A1MAPTKDM4ENPC1
SCHEMBL6996148 0.73 KMT2A (0.56) SMN1; SMN2KMT2APOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004627-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-12-24 EP disclosed
WO-2007120600-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed